AllianceBernstein’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-588,213
Closed -$30.4M 3358
2022
Q3
$30.4M Buy
588,213
+512,713
+679% +$26.5M 0.01% 706
2022
Q2
$1.87M Buy
75,500
+13,100
+21% +$325K ﹤0.01% 1987
2022
Q1
$1.56M Buy
62,400
+100
+0.2% +$2.51K ﹤0.01% 2218
2021
Q4
$2.27M Sell
62,300
-1,000
-2% -$36.4K ﹤0.01% 2050
2021
Q3
$1.08M Sell
63,300
-7,500
-11% -$128K ﹤0.01% 2454
2021
Q2
$948K Sell
70,800
-26,541
-27% -$355K ﹤0.01% 2543
2021
Q1
$4.99M Buy
97,341
+600
+0.6% +$30.7K ﹤0.01% 1553
2020
Q4
$5.99M Sell
96,741
-6,300
-6% -$390K ﹤0.01% 1385
2020
Q3
$5.65M Sell
103,041
-10,539
-9% -$578K ﹤0.01% 1279
2020
Q2
$6.54M Buy
113,580
+10,900
+11% +$627K ﹤0.01% 1185
2020
Q1
$4.13M Buy
102,680
+14,530
+16% +$584K ﹤0.01% 1267
2019
Q4
$3.49M Buy
88,150
+28,850
+49% +$1.14M ﹤0.01% 1634
2019
Q3
$402K Hold
59,300
﹤0.01% 2655
2019
Q2
$551K Buy
59,300
+12,800
+28% +$119K ﹤0.01% 2548
2019
Q1
$646K Sell
46,500
-200
-0.4% -$2.78K ﹤0.01% 2424
2018
Q4
$509K Hold
46,700
﹤0.01% 2466
2018
Q3
$590K Hold
46,700
﹤0.01% 2546
2018
Q2
$615K Buy
46,700
+6,600
+16% +$86.9K ﹤0.01% 2529
2018
Q1
$545K Buy
40,100
+2,600
+7% +$35.3K ﹤0.01% 2493
2017
Q4
$223K Hold
37,500
﹤0.01% 2820
2017
Q3
$278K Sell
37,500
-122,187
-77% -$906K ﹤0.01% 2783
2017
Q2
$1.5M Sell
159,687
-20,400
-11% -$191K ﹤0.01% 2026
2017
Q1
$1.31M Sell
180,087
-229,553
-56% -$1.67M ﹤0.01% 2072
2016
Q4
$3.03M Buy
409,640
+377,940
+1,192% +$2.8M ﹤0.01% 1516
2016
Q3
$191K Hold
31,700
﹤0.01% 2837
2016
Q2
$142K Buy
+31,700
New +$142K ﹤0.01% 2857
2015
Q2
Sell
-4,300
Closed -$32K 3324
2015
Q1
$32K Buy
4,300
+400
+10% +$2.98K ﹤0.01% 3181
2014
Q4
$27K Sell
3,900
-800
-17% -$5.54K ﹤0.01% 3187
2014
Q3
$21K Hold
4,700
﹤0.01% 3187
2014
Q2
$27K Sell
4,700
-2,700
-36% -$15.5K ﹤0.01% 3179
2014
Q1
$49K Sell
7,400
-8,382
-53% -$55.5K ﹤0.01% 3112
2013
Q4
$91K Sell
15,782
-9,435
-37% -$54.4K ﹤0.01% 2932
2013
Q3
$140K Sell
25,217
-10,053
-29% -$55.8K ﹤0.01% 2917
2013
Q2
$499K Buy
+35,270
New +$499K ﹤0.01% 2484